CCL4 and Hepatic fibrosis: Similarly, miR-17-5p, a regulator of TGF-β/Smad pathway, was up-regulated in CCL4-induced hepatic fibrosis models in mice and was also elevated in serum of patients with cirrhosis compared to healthy controls [50].